Incidence of thromboembolic events in patients with primary Sjögren's syndrome

Scandinavian Journal of Rheumatology

Volumn 37, Issue 2, 2008, Pages 127-129

  Haga, H J ^a,c   Jacobsen, E M ^b   Peen, E ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Reumaklinik Danmark ApS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PROTEIN C; PROTEIN S; WARFARIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC KIT; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; INCIDENCE; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SJOEGREN SYNDROME; THROMBOEMBOLISM;

EID: 42149145606     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740701716843     Document Type: Article

References (13)

1. Jonsson R, Haga H-J, Gordon T. Sjögren's syndrome. In Koopman WJ, editor. Arthritis and allied conditions - a textbook of rheumatology. 14th edn, Philadelphia: Lippincott Williams & Wilkins, 2001:1736-59.
2. Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Munoz J, et al. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 1997;15:361-5.
3. Fauchais AL, Lambert M, Launay D, Michon-Pasturel U, Queyrel V, Nguyen N, et al. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 74 patients. Lupus 2004;13:245-8.
4. Ingram SB, Goodnight SH, Bennet M. An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases. Arthritis Rheum 1987;30:1167-72.
5. Ulvestad E, Kanestrøm A, Tengner P, Gjerde S, Sundal J, Haga H-J. Anti-cardiolipin autoantibodies and pulmonary embolism. A case for a common cause. Scand J Rheumatol 2000;29:330-3.
6. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of prospective concerted action by the European Community. Arthritis Rheum 1993;36:340-7.
7. Schetlein R, Sletnes KE, Wisløff F. A quantitative, semi-automated and computer-assisted test for lupus anticoagulant. Thromb Res 1993;69:239-50.
8. Jacobsen EM, Barna-Cler L, Taylor JM, Triplett DA, Wisløff F. The Lupus-Ratio test - an interlaboratory study on the detection of lupus anticoagulants by an APTT-based, integrated, and semi-quantitative test. Thromb Haemost 2000;83:704-8.
9. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
10. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
11. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1000 patients. Medicine (Baltimore) 1999;78:167-75.
12. Asherson RA, Fei HM, Staub HL, Khamashta MA, Hughes GRV, Fox RI. Antiphospholipid antibodies and HLA associations in primary Sjögren's syndrome. Ann Rheum Dis 1992;51:495-8.
13. Jedryka-Goral A, Jagiello P, D'Cruz DP, Maldykowa H, Khamashta MA, Hughes GRV. Isotype profile and clinical relevance of anticardiolipin antibodies in Sjögren's syndrome. Ann Rheum Dis 1992;51:889-91.